Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
West Indian med. j ; West Indian med. j;69(5): 368-371, 2021. graf
Article in English | LILACS-Express | LILACS | ID: biblio-1515672

ABSTRACT

ABSTRACT A 51-year-old male developed traumatic pseudoaneurysms of the right- and left-posterior cerebral arteries following endoscopic resection of a pituitary adenoma. The right-sided aneurysm resolved spontaneously but the left progressed in size. This was treated endovascularly, with successful embolization of the sac. This is the first report of this approach to the management of a pseudoaneurysm of the posterior cerebral arteries to our knowledge.

2.
Med Oral Patol Oral Cir Bucal ; 25(1): e49-e55, 2020 Jan 01.
Article in English | MEDLINE | ID: mdl-31880289

ABSTRACT

BACKGROUND: The objective of this study investigated the distribution of immature dendritic cells (DCs), Langerhans cells and plasmacytoid DCs in oral submucous fibrosis (OSMF), OSMF associated with oral squamous cell carcinoma (OSMF-OSCC), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC). MATERIAL AND METHODS: Fourteen cases of OSMF, 9 of OSMF-OSCC, 8 of OL¸ 45 of OSCC and 8 of normal epithelium were retrospectively retrieved and their diagnoses confirmed. Immunoreactions against CD1a, CD207 e CD303 were performed and the number of positive cells quantified. RESULTS: A significant decrease of CD1a+ was found in OSMF (p≤0.05), OSMF-OSCC (p ≤ 0.01), and OSCC (p ≤ 0.001) when compared to normal epithelium. For CD207+ the significance decrease was observed in OSMF-OSCC (p ≤ 0.05), and OSCC (p ≤ 0.01) when compared with normal epithelium, and in OSMF when compared with OL (p ≤ 0.05). There was no significant difference for CD303, but increased in CD303+ was observed in OSCC when compared with normal epithelium. CONCLUSION: The decrease in the number of CD1a+ and CD207+ cells may be associate to the development of oral OSCC, and in OPMDs they might be indicators of malignant transformation.


Subject(s)
Carcinoma, Squamous Cell , Mouth Neoplasms , Oral Submucous Fibrosis , Antigens, CD , Humans , Lectins, C-Type , Leukoplakia, Oral , Mannose-Binding Lectins , Retrospective Studies
3.
Clin Transl Oncol ; 18(9): 937-44, 2016 Sep.
Article in English | MEDLINE | ID: mdl-26742936

ABSTRACT

PURPOSE: Data on prognostic factors in patients with metastatic osteosarcoma treated with uniform chemotherapy protocol are lacking. The objective of this study was to analyze demographic data, treatment outcome and prognostic factors for patients with metastatic osteosarcoma at our center treated with a uniform chemotherapy protocol without high dose methotrexate. METHODS: This is a single-institutional data review of patients treated between June 2003 and December 2012 with neoadjuvant chemotherapy, local site surgery followed by adjuvant chemotherapy and metastasectomy at completion of adjuvant chemotherapy. RESULTS: 102 patients of metastatic osteosarcoma were treated with a median age of 18 years (range 8-48 years), male to female ratio of 3.3:1 and median symptom duration of 4 months. EFS and OS at 5 years were 12.7 ± 0.1 and 28.1 ± 0.1 %, respectively. On multivariate analysis, elevated serum alkaline phosphatase (p < 0.001) and number of metastasis >3 (p = 0.04) were predictive of lower EFS, whereas elevated serum alkaline phosphatase (p = 0.01), number of metastasis >3 (p = 0.05), and margin positivity (p < 0.001) were predictive of lower OS. CONCLUSIONS: This is the largest data on metastatic osteosarcoma treated with a uniform chemotherapy protocol without high dose methotrexate. The data showed prognostic factors similar to what have been observed previously such as elevated serum alkaline phosphatase and >3 metastatic lesions in lung predicting inferior outcome. Notably our survival was comparable to data from other studies despite our practice of delaying metastasectomy to completion of chemotherapy rather than performing the same along with local site surgery.


Subject(s)
Antineoplastic Agents/therapeutic use , Bone Neoplasms/pathology , Osteosarcoma/pathology , Adolescent , Adult , Bone Neoplasms/drug therapy , Bone Neoplasms/mortality , Chemotherapy, Adjuvant/methods , Child , Disease-Free Survival , Female , Humans , Kaplan-Meier Estimate , Male , Metastasectomy , Middle Aged , Neoadjuvant Therapy/methods , Neoplasm Metastasis/therapy , Osteosarcoma/drug therapy , Osteosarcoma/mortality , Prognosis , Proportional Hazards Models , Treatment Outcome , Young Adult
4.
Clin Transl Oncol ; 18(2): 132-7, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26169214

ABSTRACT

BACKGROUND: Multiple myeloma (MM) is a B-cell malignancy characterized by the accumulation of clonal population of plasma cells in the bone marrow (BM). A variety of angiogenic factors, proteases, reactive oxygen species and inflammatory cytokines induce the formation of an extensive and suitable BM microenvironment. Previous studies have established the importance of angiogenic factors, inflammatory molecules and oxidative stress in MM but their interplay and effect on each other are not being taken together. METHODS: Circulatory levels of VEGF, angiopoietin-2 (Ang-2), IL-6 and TNF-α along with the activity of superoxide dismutase (SOD) and glutathione peroxidase (GPx) were investigated in 112 subjects including 62 MM patients and 50 healthy controls. Inter-stage analysis was done to evaluate the association of these molecules with the severity of disease. Pearson correlation was determined to find interrelationship, if any, between these molecules. RESULTS: We have observed elevated levels of VEGF, Ang-2, IL-6, TNF-α and decreased activity of SOD, GPx in MM patients in comparison to controls. All these molecules also showed a trend with the severity of disease. We have found strong association between these factors upon their correlation and regression analysis. CONCLUSION: This study is a step toward understanding the indepth contribution of angiogenesis, inflammation and oxidative stress together in making BM microenvironment suitable for growth, survival and proliferation of malignant plasma cells in MM.


Subject(s)
Inflammation/pathology , Multiple Myeloma/pathology , Neovascularization, Pathologic/pathology , Oxidative Stress/physiology , Tumor Microenvironment/physiology , Adult , Aged , Bone Marrow/pathology , Enzyme-Linked Immunosorbent Assay , Female , Humans , India , Male , Middle Aged , Multiple Myeloma/blood supply
5.
Clin Transl Oncol ; 18(3): 310-6, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26243399

ABSTRACT

BACKGROUND: Data on treatment outcome and prognostic factors in patients with metastatic soft tissue sarcoma (STS) are limited in the literature. METHODS: A total of 119 patients with metastatic STS treated between June 2003 and December 2012 were analyzed for treatment outcome and prognostic factors. RESULTS: Median age was 37 years (range 2-72 years) with a male to female ratio of 1.5:1. Most common histologic subtypes were synovial sarcoma (36 %) and leiomyosarcoma (16 %). Median tumor size was 12 cm (range 1.6-30 cm). Twenty-four (20 %) patients were treated with multimodality therapy and 80 % patients received systemic chemotherapy alone. At a median follow-up of 10 months (range 1-66 months), the 2-year EFS and OS were 10 and 19 %, respectively, with a median EFS and OS of 6 and 10 months, respectively. Univariate analysis identified albumin ≤4 g/dl (p = 0.001), histologic subtypes other than synovial sarcoma (p = 0.02), non-extremity tumors (p = 0.03) and single modality treatment (p = 0.03) as factors predicting poor EFS; however, for OS, hemoglobin ≤10 g/dl (p = 0.02), tumor size >10 cm (p = 0.01) and single modality treatment (p = 0.04) were identified as poor prognostic factors. Multivariate analysis identified only serum albumin ≤4 g/dl (p = 0.002, HR 0.47, 95 % CI 0.29-0.75) associated with poor EFS; however, for OS, hemoglobin ≤10 g/dl (p = 0.009, HR 0.49, 95 % CI 0.29-0.83), tumor size >10 cm (p = 0.003, HR 2.11, 95 % CI 1.28-3.47) and single modality treatment (p = 0.01, HR 0.47, 95 % CI 0.25-0.86) emerged as poor prognostic factors. CONCLUSIONS: Serum albumin, tumor size, hemoglobin and treatment modality affect survival in metastatic STS.


Subject(s)
Sarcoma/pathology , Sarcoma/therapy , Soft Tissue Neoplasms/pathology , Soft Tissue Neoplasms/therapy , Adolescent , Adult , Aged , Child , Child, Preschool , Combined Modality Therapy , Disease-Free Survival , Female , Hemoglobins , Humans , Infant , Kaplan-Meier Estimate , Male , Middle Aged , Multivariate Analysis , Neoplasm Metastasis , Prognosis , Proportional Hazards Models , Retrospective Studies , Sarcoma/mortality , Serum Albumin , Soft Tissue Neoplasms/mortality , Treatment Outcome , Young Adult
6.
Am. heart j ; 178: 145-150, 2016. tab
Article in English | Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-1059477

ABSTRACT

Clinical and subclinical (covert) stroke are a cause of cognitive loss and functional impairment. In the AVERROES trial, we performed serial brain MRI scans in asubgroup to explore the effect of apixaban, compared with aspirin, on clinical and covertbrain infarction and on microbleeds in patients with atrial fibrillation. Methods: We performed brain MRI (T1, T2, FLAIR and GRE sequences) in 1,180 atbaseline and in 925 participants at follow-up. Mean interval from baseline to follow-up MRIscans was 1.0 year. The primary outcome was a composite of clinical ischemic stroke andcovert ‘embolic pattern’ infarction (defined as infarction > 1.5cm, cortical-based or newmulti-territory infarction). Secondary outcomes included new MRI-detected brain infarctsand microbleeds and change in white matter hyperintensities...


Subject(s)
Courses , Magnetic Resonance Spectroscopy , Atrial Fibrillation
7.
J Glob Infect Dis ; 3(2): 189-94, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21731309

ABSTRACT

This report analyses the trends in the cholera epidemic that hit Ecuador in 1991. The study is based on personal experiences and analysis of epidemiological databases from the Ministry of Public Health of Ecuador. The number of cases and initial attack rates in an immunologically naive population are described by province. An analysis of the Andean and coastal cholera patterns of transmission are described along with its associated risk factors. The logistical, environmental, and socio-cultural risk factors prevalent during the epidemic and the control measures implemented are also reviewed. Also, the role of the epidemic in the development of the public health and healthcare resources in Ecuador is discussed here. Current data indicate favorable conditions for another outbreak of cholera in Ecuador. In view of the existing risk factors, new strategies are proposed to prevent such an epidemic in the future.

8.
J Assoc Physicians India ; 48(6): 568-72, 2000 Jun.
Article in English | MEDLINE | ID: mdl-11273531

ABSTRACT

OBJECTIVE: The study was conducted to evaluate usefulness of single strand conformation polymorphism (SSCP) over DNA sequencing in the diagnosis of rifampicin (Rif)-resistant tuberculosis. METHODS: Forty seven isolates of Mycobacterium tuberculosis (MTB) Rif-resistant and 25 Rif-sensitive were obtained from Vancouver, Mexico city and New Delhi and were analyzed by polymerase chain reaction (PCR) amplification of rpoB gene and the mutations were identified by DNA sequencing and SSCP. RESULTS: The mutations observed by DNA sequencing in 47 RIF-resistant isolates showed that the most common mutation among Vancouver isolates was in codon 526, Hist-->Arg and in Mexico isolates was in codon 531, Ser-Leu and New Delhi isolates was in codon 516, Asp-->Val. Using fluorescence based PCR-SSCP, it was possible to distinguish Rif-resistant isolates from Rif-sensitive isolates. CONCLUSION: DNA sequencing is a highly accurate method for the detection of mutations associated with drug resistance in tuberculosis but is more expensive and requires special equipment and personnel. SSCP is a simple, accurate method and suitable for analysis of large number of samples and the results are available in less than 72 hours.


Subject(s)
DNA Mutational Analysis , Mycobacterium tuberculosis/genetics , Plant Proteins/genetics , Polymorphism, Genetic/genetics , Polymorphism, Single-Stranded Conformational , Rifampin/therapeutic use , Tuberculosis, Multidrug-Resistant/drug therapy , DNA-Directed RNA Polymerases , Humans , India , Microbial Sensitivity Tests , Mycobacterium tuberculosis/drug effects , Polymerase Chain Reaction , Rifampin/adverse effects , Tuberculosis, Multidrug-Resistant/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL